≡ Risteys
FG R12 + FR

Documentation Changelog GitHub Contact & Feedback

Other and unspecified hydrocephalus

DOID EFO Endpoint Browser PheWeb

G6_HCOTHUNS

Endpoint definition

↥

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 — G91.8, G91.9
  • Hospital discharge: ICD-8 — 34793
  • Cause of death: ICD-10 — G91.8, G91.9
  • Cause of death: ICD-8 — 34793

2 out of 7 registries used, show all original rules.

665

4. Check minimum number of events

None

665

5. Include endpoints

None

665

6. Filter based on genotype QC (FinnGen only)

665

Control definitions (FinnGen only)

Control exclude
G6_HYDROCEPH

Extra metadata

Level in the ICD hierarchy
3
First used in FinnGen datafreeze
DF2

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 6159 3013 3080
Only index persons 4640 2370 2270
Unadjusted period prevalence (%)
Whole population 0.09 0.09 0.09
Only index persons 0.09 0.09 0.09
Median age at first event (years)
Whole population 56.12 58.51 53.59
Only index persons 54.55 57.40 51.57

-FinnGen-

Key figures

All Female Male
Number of individuals 665 366 299
Unadjusted period prevalence (%) 0.13 0.12 0.13
Median age at first event (years) 60.24 58.65 62.20

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
611
Matched controls
6108
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
AAF05
NOMESCO Finland
Ventriculoperitoneal shunt
+∞
323.0
302
*
G91.9
ICD-10 Finland
Hydrocephalus, unspecified
+∞
323.0
503
*
G91.2
ICD-10 Finland
Normal-pressure hydrocephalus
+∞
291.8
256
*
AAF20
NOMESCO Finland
Revision of shunt of ventricle of brain
+∞
180.4
164
*
G91.1
ICD-10 Finland
Obstructive hydrocephalus
+∞
179.2
163
*
G91.0
ICD-10 Finland
Communicating hydrocephalus
+∞
164.2
150
*
G91.8
ICD-10 Finland
Other hydrocephalus
+∞
134.5
124
*
AAF00
NOMESCO Finland
Ventriculostomy
285.6
117.3
116
5
AA7AA
NOMESCO Finland
Liquor cerebri shunt X-ray examinatin without contrast
+∞
110.9
103
*
AA1AD
NOMESCO Finland
CT of head and brain
7.3
106.3
341
900
T85.0
ICD-10 Finland
Mechanical complication of ventricular intracranial (communicating) shunt
+∞
96.5
90
*
AAF25
NOMESCO Finland
Removal of shunt of ventricle of brain
+∞
81.1
76
*
AA1AA
NOMESCO Finland
Head X-ray examination
74.1
79.0
89
14
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
14.4
73.1
129
111
AAF15
NOMESCO Finland
Ventriculoatrial shunt
+∞
61.5
58
*
AAF99
NOMESCO Finland
Other shunt operation on ventricle of brain or intracerebral cyst
649.3
60.8
59
*
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
7.2
52.8
140
243
I69.0
ICD-10 Finland
Sequelae of subarachnoid haemorrhage
56.6
44.4
52
10
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
6.3
44.4
128
245
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
6.2
43.8
129
253
R51.80
ICD-10 Finland
Headache
4.6
41.2
165
456
AAF50
NOMESCO Finland
Third ventriculostomy
+∞
40.0
38
*
I60.9
ICD-10 Finland
Subarachnoid haemorrhage, unspecified
30.4
39.7
53
19
AAA20
NOMESCO Finland
Insertion of intraventricular pressure monitoring device
401.3
38.5
38
*
ZXD05
NOMESCO Finland
Urgent procedure
3.1
35.2
270
1245
R26.8
ICD-10 Finland
Other and unspecified abnormalities of gait and mobility
13.1
30.3
54
45
N03AX14
ATC
levetiracetam; systemic
9.7
29.9
62
70
34793
ICD-8 Finland
Other disease of brain, Hydrocephalus acquisitus NUD
+∞
28.3
27
*
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
5.1
28.0
94
210
PA2CC
NOMESCO Finland
Cerebral very extensive angiography with X-ray
43.5
27.0
33
8
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
3.3
26.5
156
575
111
Kela drug reimbursment
Epilepsy and comparable convulsive disorders
5.5
26.5
83
171
Z98.2
ICD-10 Finland
Presence of cerebrospinal fluid drainage device
+∞
26.2
25
*
3313A
ICD-9 Finland
Other cerebral degenerations, Communicating hydrocephalus
+∞
26.2
25
*
N03AG01
ATC
valproic acid; systemic, rectal
5.2
24.9
81
174
ZXE10
NOMESCO Finland
More than one and less than three hours
2.5
24.4
275
1505
G40.9
ICD-10 Finland
Epilepsy, unspecified
6.7
24.4
64
105
182
Kela drug reimbursment
Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide
9.9
23.2
47
51
2132
FHL
Ventricular operators sunt
+∞
22.0
21
*
G04BD07
ATC
tolterodine; oral
5.1
21.7
71
153
G40.29
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures
10.4
21.4
42
43
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
3.0
21.1
137
533
G91.3
ICD-10 Finland
Post-traumatic hydrocephalus, unspecified
+∞
21.0
20
*
G97.2
ICD-10 Finland
Intracranial hypotension following ventricular shunting
+∞
19.9
19
*
G93.0
ICD-10 Finland
Cerebral cysts
76.1
19.8
22
*
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
6.5
19.2
51
85
S06.5
ICD-10 Finland
Traumatic subdural haemorrhage
6.0
18.1
51
92
PA2BC
NOMESCO Finland
Cerebral extensive angiography with X-ray
20.8
17.9
26
13
WX408
NOMESCO Finland
General anesthesy, balanced
2.4
17.9
198
1034
Q03.9
ICD-10 Finland
Congenital hydrocephalus, unspecified
+∞
17.8
17
*
3314A
ICD-9 Finland
Other cerebral degenerations, Obstructive hydrocephalus
+∞
17.8
17
*
TAB00
NOMESCO Finland
Lumbar puncture
5.1
17.8
57
120
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
2.7
17.8
138
596
XA800
NOMESCO Finland
Neuropsychological investigation
5.2
17.2
54
111
I69.1
ICD-10 Finland
Sequelae of intracerebral haemorrhage
16.5
17.2
27
17
L28
ICPC
Limited function/disability (L)
2.7
17.1
136
592
I62.0
ICD-10 Finland
Nontraumatic subdural haemorrhage
18.0
17.1
26
15
2133
FHL
Suntin revisio
+∞
16.7
16
*
G93.2
ICD-10 Finland
Benign intracranial hypertension
+∞
16.7
16
*
PA2MT
NOMESCO Finland
Endovascular closure of very extensive brain aneurysm
174.5
16.6
17
*
PA2BD
NOMESCO Finland
Extensive CT angiography of brain
11.6
16.4
30
27
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
2.2
16.0
219
1250
R42
ICD-10 Finland
Dizziness and giddiness
2.3
15.9
177
918
TAA40
NOMESCO Finland
Cathetrisation of cerebrospinal fluid through skin
+∞
15.7
15
*
PA3AC
NOMESCO Finland
Carotis angiography with X-ray
87.4
15.6
17
*
F03
ICD-10 Finland
Unspecified dementia
4.2
15.3
59
151
AAD10
NOMESCO Finland
Evacuation of chronic subdural haematoma
8.8
15.2
32
38
R53
ICD-10 Finland
Malaise and fatigue
2.4
15.1
156
776
AA1AG
NOMESCO Finland
Short MRI examination of brain with median intensity magnet
10.4
15.1
29
29
N05AH04
ATC
quetiapine; oral
2.7
14.9
115
487
A28
ICPC
Limited function/disability NOS
2.4
14.7
139
662
H47.1
ICD-10 Finland
Papilloedema, unspecified
27.9
14.3
19
7
N29
ICPC
Neurological sympt/complt other
7.5
14.2
33
46
G04BD08
ATC
solifenacin; oral
3.5
14.2
68
210
I61.9
ICD-10 Finland
Intracerebral haemorrhage, unspecified
10.4
14.1
27
27
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
2.4
14.1
135
645
N18
ICPC
Paralysis/weakness
7.0
13.9
34
51
R56.8
ICD-10 Finland
Other and unspecified convulsions
4.0
13.8
57
155
N05AX08
ATC
risperidone; systemic
3.3
13.7
71
233
PA2LT
NOMESCO Finland
Endovascular closure of extensive brain aneurysm
76.9
13.6
15
*
PA2KT
NOMESCO Finland
Endovascular closure of brain aneurysm
76.9
13.6
15
*
AAC00
NOMESCO Finland
Ligature of intracranial aneurysm
11.3
13.6
25
23
Q03.0
ICD-10 Finland
Malformations of aqueduct of Sylvius
+∞
13.6
13
*
G91
ICD-10 Finland
Hydrocephalus
+∞
13.6
13
*
I67.1
ICD-10 Finland
Cerebral aneurysm, nonruptured
8.0
13.5
30
39
U04
ICPC
Incontinence urine
4.3
13.5
50
123
N30.0
ICD-10 Finland
Acute cystitis
2.5
13.3
112
500
T90.5
ICD-10 Finland
Sequelae of intracranial injury
15.5
13.2
21
14
A06AD11
ATC
lactulose; oral
2.4
12.9
117
541
I60.1
ICD-10 Finland
Subarachnoid haemorrhage from middle cerebral artery
20.6
12.5
18
9
N06AB04
ATC
citalopram; systemic
2.2
12.5
144
750
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
2.9
12.4
82
315
G04BD12
ATC
mirabegron; oral
2.8
12.2
81
313
Z03.3
ICD-10 Finland
Observation for suspected nervous system disorder
3.4
12.0
59
186
I60.2
ICD-10 Finland
Subarachnoid haemorrhage from anterior communicating artery
47.6
11.9
14
*
AAB00
NOMESCO Finland
Extirpation of intracranial lesion
9.2
11.8
24
27
Y83.1
ICD-10 Finland
Surgical operation with implant of artificial internal device as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
9.2
11.8
24
27
N05BA01
ATC
diazepam; systemic, rectal
2.4
11.7
103
469
N05BA09
ATC
clobazam; oral
12.9
11.7
20
16
2130
FHL
Ventricular atrial shunt
+∞
11.5
11
*
N03AB02
ATC
phenytoin; systemic
8.1
11.5
25
32
I60.7
ICD-10 Finland
Subarachnoid haemorrhage from intracranial artery, unspecified
35.7
11.3
14
*
I60.0
ICD-10 Finland
Subarachnoid haemorrhage from carotid siphon and bifurcation
35.7
11.3
14
*
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
3.1
11.2
64
225
G40.22
ICD-10 Finland
Complex partial epileptic seizure with secondary generalization
6.0
11.2
30
52
SPAT1216
SPAT
Assessment of functional ability
2.2
11.1
123
627
AAB10
NOMESCO Finland
Partial excision of intracranial lesion
12.2
10.9
19
16
N03AF02
ATC
oxcarbazepine; oral
4.2
10.8
41
104
183
Kela drug reimbursment
Lamotrigin and topiramate
10.3
10.6
20
20
S06.0
ICD-10 Finland
Concussion
2.6
10.6
80
336
N05AH03
ATC
olanzapine; systemic
3.6
10.5
48
143
N28
ICPC
Limited function/disability (N)
6.6
10.4
26
41
SPAT1217
SPAT
Assessment of need for services (elderly/care support)
2.7
10.4
71
279
P20
ICPC
Memory disturbance
2.3
10.2
102
490
WX404
NOMESCO Finland
Intravenous generell anesthesy
2.1
10.2
136
746
SPAT1229
SPAT
Assessment of need for aid
2.7
10.2
71
284
SPAT1301
SPAT
No procedures
1.8
10.1
208
1339
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
2.8
10.0
66
254
N03AF01
ATC
carbamazepine; oral, rectal
3.5
10.0
46
138
G04BD04
ATC
oxybutynin; oral, transdermal
3.2
10.0
52
172
R11
ICD-10 Finland
Nausea and vomiting
2.7
10.0
69
274
R41.8
ICD-10 Finland
Other and unspecified symptoms and signs involving cognitive functions and awareness
2.6
9.9
73
301
SPAT1226
SPAT
Implementation of occupational therapy rehabilitation plan
4.7
9.9
33
74
PA2YT
NOMESCO Finland
Cerebral artery PTA with stent
26.5
9.8
13
5
GBB00
NOMESCO Finland
Tracheostomy
10.9
9.8
18
17
AA1CM
NOMESCO Finland
Extensive MRI examination of brain with 3 Tesla magnet
6.0
9.8
26
45
NA7BG
NOMESCO Finland
Spine and spinal cord MRI examination with high intensity magnet
13.7
9.7
16
12
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
2.6
9.7
72
299
N04BA02
ATC
levodopa and decarboxylase inhibitor; oral
3.9
9.7
39
105
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
2.2
9.7
109
555
SPAT1262
SPAT
Handing over of treatment supplies
2.1
9.6
119
634
G41.9
ICD-10 Finland
Status epilepticus, unspecified
17.9
9.4
14
8
N06AX11
ATC
mirtazapine; oral
1.8
9.4
189
1203
AA1BM
NOMESCO Finland
MRI examination of brain with 3 Tesla magnet
12.6
9.4
16
13
7423A
ICD-9 Finland
Other congenital anomalies of nervous system, Congenital hydrocephalus
+∞
9.4
9
*
74200
ICD-8 Finland
Congenital hydrocephalus, Communicans
+∞
9.4
9
*
AWB00
NOMESCO Finland
Reoperation for superficial infection in surgery of the nervous system
+∞
9.4
9
*
AAF10
NOMESCO Finland
Lumboperitoneal shunt
+∞
9.4
9
*
I60.4
ICD-10 Finland
Subarachnoid haemorrhage from basilar artery
+∞
9.4
9
*
Z01.0
ICD-10 Finland
Examination of eyes and vision
2.1
9.4
115
605
Z02.4
ICD-10 Finland
Examination for driving licence
0.4
9.3
40
922
I63.9
ICD-10 Finland
Cerebral infarction, unspecified
2.3
9.3
87
407
N03AX18
ATC
lacosamide; systemic
11.7
9.1
16
14
N03AX09
ATC
lamotrigine; oral
3.8
9.1
38
106
307
Kela drug reimbursment
Tacrine, donepezil, rivastigmine, galantamine and other major and expensive drugs used to treat Alzheimer's disease
3.3
9.1
45
144
H47.2
ICD-10 Finland
Optic atrophy
15.9
9.1
14
9
H53.4
ICD-10 Finland
Visual field defects
5.2
9.0
27
54
G81.1
ICD-10 Finland
Spastic hemiplegia
37.3
9.0
11
*
R50.9
ICD-10 Finland
Fever, unspecified
2.2
9.0
99
501
ZXC86
NOMESCO Finland
Use of endoscopic device
18.9
9.0
13
7
R41.0
ICD-10 Finland
Disorientation, unspecified
4.1
8.9
33
83
N32.82
ICD-10 Finland
Instability of the detrusor vesicae muscle
8.8
8.8
18
21
R1230
NOMESCO Finland
Neuropsychological evaluation of need and possibilities to rehabilitation
10.9
8.8
16
15
N06DA02
ATC
donepezil; oral
2.9
8.8
52
188
R32
ICD-10 Finland
Unspecified urinary incontinence
4.5
8.7
30
70
T85.7
ICD-10 Finland
Infection and inflammatory reaction due to other internal prosthetic devices, implants and grafts
50.7
8.7
10
*
N39.4
ICD-10 Finland
Other specified urinary incontinence
2.7
8.6
61
245
I69.3
ICD-10 Finland
Sequelae of cerebral infarction
2.6
8.6
64
265
WX402
NOMESCO Finland
General anaesthesia
2.1
8.5
96
489
K90
ICPC
Stroke/cerebrovascular accident
3.9
8.4
33
88
G94.2
ICD-10 Finland
Hydrocephalus in other diseases classified elsewhere
+∞
8.3
8
*
J18.9
ICD-10 Finland
Pneumonia, unspecified
1.8
8.3
164
1031
G40.20
ICD-10 Finland
Complex partial seizures with only alteration of consciousness
7.2
8.3
19
27
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
2.1
8.2
91
461
N02BE01
ATC
paracetamol; systemic, rectal
1.8
8.1
502
4371
AAL00
NOMESCO Finland
Endovascular occlusion of intracranial aneurysm
33.8
8.1
10
*
PA7CD
NOMESCO Finland
CT angiography of neck and brain, extensive
10.2
8.1
15
15
N99
ICPC
Neurological disease other
6.7
7.9
19
29
A49.9
ICD-10 Finland
Bacterial infection, unspecified
2.2
7.9
79
382
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
1.7
7.9
180
1179
SPAT1222
SPAT
Counselling/guidance promoting independent living
2.0
7.8
106
583
AA1CD
NOMESCO Finland
Very extensive CT of head and brain
5.2
7.8
23
46
N02AA05
ATC
oxycodone; systemic
2.0
7.6
101
549
TJD20
NOMESCO Finland
Change of gastrostomy tube
18.6
7.6
11
6
WX730
NOMESCO Finland
Conventional respirator
6.3
7.6
19
31
I61.0
ICD-10 Finland
Intracerebral haemorrhage in hemisphere, subcortical
6.3
7.6
19
31
G00.9
ICD-10 Finland
Bacterial meningitis, unspecified
25.4
7.6
10
*
I60.3
ICD-10 Finland
Subarachnoid haemorrhage from posterior communicating artery
25.4
7.6
10
*
NA7CG
NOMESCO Finland
Spine and spinal cord extensive MRI examination with high intensity magnet
9.0
7.6
15
17
G40.10
ICD-10 Finland
Simple partial seizures
10.2
7.6
14
14
ABE50
NOMESCO Finland
Occipitocervical decompression
81.0
7.4
8
*
PA4AC
NOMESCO Finland
Vertebralis angiography with X-ray
81.0
7.4
8
*
G40.19
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures
9.5
7.3
14
15
N31.9
ICD-10 Finland
Neuromuscular dysfunction of bladder, unspecified
9.5
7.3
14
15
AAF45
NOMESCO Finland
Fenestration of intracranial cyst
+∞
7.3
7
*
AAA27
NOMESCO Finland
Insertion of intracerebral pressure monitoring device
+∞
7.3
7
*
AAW99
NOMESCO Finland
Other intracranial operation
+∞
7.3
7
*
G44.2
ICD-10 Finland
Tension-type headache
2.1
7.3
79
396
WYA30
NOMESCO Finland
Preparations for expected poor cooperation
2.4
7.3
59
256
XKC03
NOMESCO Finland
Water cystometry
4.0
7.2
27
70
Q07.0
ICD-10 Finland
Arnold-Chiari syndrome
20.3
7.1
10
5
M03BX01
ATC
baclofen; systemic
6.1
7.1
18
30
G81.9
ICD-10 Finland
Hemiplegia, unspecified
7.1
7.0
16
23
R33
ICD-10 Finland
Retention of urine
2.5
7.0
55
236
N05CF01
ATC
zopiclone; oral
1.7
6.9
192
1324
PA2AD
NOMESCO Finland
CT angiography of brain
14.0
6.9
11
8
N05AB03
ATC
perphenazine; systemic, rectal
3.6
6.9
29
83
JDB10
NOMESCO Finland
Percutaneous gastrostomy
8.4
6.9
14
17
NA7DG
NOMESCO Finland
Spine and spinal cord very extensive MRI examination with high intensity magnet
6.8
6.8
16
24
Z2445
NOMESCO Finland
Psychologist
3.2
6.8
34
111
WX704
NOMESCO Finland
Intubation
2.6
6.8
50
205
112
Kela drug reimbursment
Severe psychotic and other severe mental disorders
2.6
6.8
48
196
A41.9
ICD-10 Finland
Sepsis, unspecified
3.2
6.7
34
112
N06AB10
ATC
escitalopram; oral
1.9
6.7
110
647
ZXE20
NOMESCO Finland
More than three and less than five hours
2.0
6.7
90
491
WYA20
NOMESCO Finland
Home visit
5.3
6.7
19
37
XCK00
NOMESCO Finland
Perimetry
2.6
6.7
49
201
G40.12
ICD-10 Finland
Simple partial seizures with secondary generalization
7.9
6.6
14
18
J01EA01
ATC
trimethoprim; systemic
1.7
6.6
155
1018
H53.2
ICD-10 Finland
Diplopia
3.5
6.6
29
86
J69.0
ICD-10 Finland
Pneumonitis due to food and vomit
4.6
6.5
21
47
504
Kela drug reimbursment
Conditions requiring daily forced enteral nutrition
6.3
6.5
16
26
SPAT1137
SPAT
Taking care of patient’s/customer’s hygiene
2.5
6.5
49
207
ZXD00
NOMESCO Finland
Emergency procedure
3.7
6.5
26
72
Y83.9
ICD-10 Finland
Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
4.0
6.4
24
62
AAK80
NOMESCO Finland
Partial excision of skull cap
70.6
6.4
7
*
I61.5
ICD-10 Finland
Intracerebral haemorrhage, intraventricular
70.6
6.4
7
*
NA1BG
NOMESCO Finland
Cervical spine MRI examination with high intensity magnet
3.0
6.3
34
118
I60.6
ICD-10 Finland
Subarachnoid haemorrhage from other intracranial arteries
18.2
6.3
9
5
F79.0
ICD-10 Finland
Unspecified mental retardation, with the statement of no, or minimal, impairment of behaviour
18.2
6.3
9
5
G95.0
ICD-10 Finland
Syringomyelia and syringobulbia
18.2
6.3
9
5
SPAT1053
SPAT
Memory test
1.8
6.3
106
626
N06AX16
ATC
venlafaxine; oral
2.0
6.3
76
400
R29.2
ICD-10 Finland
Abnormal reflex
+∞
6.3
6
*
2139
FHL
Other measure in this category
+∞
6.3
6
*
P52.2
ICD-10 Finland
Intraventricular (nontraumatic) haemorrhage, grade 3, and grade 4 of fetus and newborn
+∞
6.3
6
*
G80.2
ICD-10 Finland
Spastic hemiplegic cerebral palsy
27.0
6.2
8
*
N30.9
ICD-10 Finland
Cystitis, unspecified
2.7
6.1
39
148
G40.09
ICD-10 Finland
Other or unspecified partial (focal) idiopathic epilepsy or epileptic syndrome with local onset
12.7
6.1
10
8
G03.9
ICD-10 Finland
Meningitis, unspecified
12.7
6.1
10
8
G30.9
ICD-10 Finland
Alzheimer disease, unspecified
3.2
6.1
30
98
XKD06
NOMESCO Finland
Physiologic investigation of micturition
3.6
6.1
25
71

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
152
41
47.76
252.54
3.2
1.2
—
—
—
0
0
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
186
106
23.97
238.42
3.1
1.3
e6/l
26.6
7.8
1.41
158
76
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
186
106
23.97
238.42
3.2
1.3
e6/l
1349.1
1249.6
0.03
164
79
(3044290) Cell count panel - Cerebral spinal fluid
150
92
20.76
184.10
3.3
1.4
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
97
43
26.24
135.77
2.8
1.5
—
—
—
0
0
(3035999) Lactate [Moles/volume] in Cerebral spinal fluid
76
28
30.52
113.25
2.8
1.2
mmol/l
2.1
1.9
0.96
70
28
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
67
19
39.10
107.90
2.9
1.2
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
63
52
13.28
64.21
3.1
1.5
—
—
—
0
0
(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid
47
31
16.24
54.17
1.1
1.0
ng/l
241.8
287.3
0.46
18
21
(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid
47
31
16.24
54.17
1.1
1.0
ng/l
613.6
618.9
0.02
19
22
(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay
47
31
16.24
54.17
1.1
1.0
ng/l
29.0
39.1
0.60
17
20
(3005715) Vancomycin [Mass/volume] in Serum or Plasma
51
64
8.55
38.44
5.3
5.9
mg/l
10.5
10.9
0.24
46
58
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
25
22
11.77
24.14
1.7
1.1
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
56
147
4.07
19.34
3.1
1.4
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
431
3133
2.07
17.35
8.7
5.0
mmol/l
6.7
6.7
0.02
420
2941
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
263
1611
2.05
17.04
2.8
2.1
u/l
147.7
300.1
1.72
250
1517
(3026008) Bacteria identified in Urine by Culture
270
1717
1.96
15.35
4.8
3.3
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
127
615
2.32
14.74
10.7
8.0
mmol/l
1.8
1.4
0.92
104
483
(3019060) Gas panel - Arterial blood
88
364
2.63
14.34
11.5
6.0
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
321
2198
1.89
14.32
8.2
9.2
inr
1.2
1.3
0.67
119
608
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
304
2051
1.89
14.15
4.3
3.8
ng/l
74.0
56.5
0.17
222
1464
(3023368) Bacteria identified in Blood by Culture
239
1491
1.94
14.12
5.8
4.2
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
373
2726
1.84
13.10
9.3
6.8
mmol/l
1.2
1.2
1.06
302
2303
(3029937) Albumin [Presence] in Urine by Test strip
224
1404
1.90
12.81
6.6
4.1
estimate
0.0
0.0
0.50
75
475
(3003181) Sodium [Moles/volume] in Urine
39
111
3.67
12.02
1.8
1.5
mmol/l
93.7
63.7
2.67
34
95
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
345
2506
1.78
11.95
9.8
6.2
mmol/l
1.2
1.2
4.08
321
2269
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
35
96
3.79
11.37
1.8
1.5
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
22
44
5.14
10.58
1.1
1.0
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
18
30
6.14
10.44
1.2
1.2
—
—
—
0
0
(3012095) Magnesium [Moles/volume] in Serum or Plasma
144
829
1.94
10.36
4.0
3.5
mmol/l
0.8
0.8
0.73
131
770
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
154
918
1.88
9.94
2.2
1.9
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
19
36
5.40
9.68
1.7
1.9
—
—
—
0
0
(3026782) Osmolality of Urine
175
1104
1.79
9.34
3.7
2.9
mosm/kgh2o
517.0
546.8
0.97
160
938
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
271
1948
1.66
8.93
4.2
3.4
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
99
525
2.04
8.93
5.0
3.7
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
116
652
1.94
8.87
2.2
1.8
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
116
654
1.94
8.79
2.3
1.9
—
—
—
0
0
(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid
16
29
5.63
8.53
1.2
1.0
u/l
1.4
1.1
—
9
19
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
114
648
1.92
8.41
8.4
7.2
—
—
—
0
0
(3020891) Body temperature
52
218
2.50
8.22
12.2
4.6
—
—
—
0
0
(3033658) Prothrombin time (PT) actual/Normal
196
1318
1.69
8.20
4.4
3.8
%
90.0
89.2
0.18
190
1287
(40761535) Cells panel - Urine sediment
84
443
2.03
7.66
4.0
3.6
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
68
332
2.17
7.59
2.1
1.4
—
—
—
0
0
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
52
227
2.40
7.54
2.9
1.9
ug/l
0.6
2.6
0.91
46
197
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
15
29
5.27
7.48
1.1
1.1
—
—
—
0
0
(3003458) Phosphate [Moles/volume] in Serum or Plasma
118
704
1.82
7.44
6.2
5.7
mmol/l
1.0
1.1
2.39
109
647
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
269
1999
1.58
7.37
6.7
4.0
—
—
—
0
0
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
11
7
15.94
7.25
1.5
1.0
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
161
1068
1.67
6.95
2.0
1.8
nmol/l
1369.9
1177.3
2.26
136
788
(3019150) Specific gravity of Urine by Refractometry
175
1192
1.64
6.80
6.5
4.1
kg/l
1.0
1.0
0.04
22
170
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
81
440
1.96
6.79
5.8
3.8
mmol/l
1.2
1.2
0.45
73
385
(3018405) Lactate [Moles/volume] in Arterial blood
46
203
2.36
6.53
10.4
3.9
mmol/l
1.5
1.4
0.13
46
197
(3042936) Bacteria identified in Isolate by Culture
123
771
1.73
6.51
2.3
2.0
—
—
—
0
0
(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma
13
25
5.28
6.51
3.1
2.1
umol/l
66.8
45.0
1.40
13
17
(3031040) Bacteria [#/volume] in Urine by Automated count
421
3516
1.54
6.48
7.3
4.7
e6/l
5305.0
2856.2
—
8
64
(1616796) Gas panel - Central venous blood
32
119
2.77
6.43
5.8
3.4
—
—
—
0
0
(3020191) Ethanol [Moles/volume] in Serum or Plasma
17
42
4.13
6.39
1.4
1.2
promille
0.7
1.1
0.62
11
32
(3012501) Base excess in Blood by calculation
32
120
2.75
6.34
5.9
3.4
mmol/l
1.9
2.7
1.10
24
80
(3000850) Epithelial cells [#/volume] in Urine
168
1159
1.60
6.12
3.6
2.7
e6/l
7.1
5.6
0.62
155
1017
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
167
1158
1.59
5.94
1.7
1.7
pmol/l
479.7
438.1
0.75
136
951
(3035350) Ketones [Presence] in Urine by Test strip
322
2573
1.49
5.91
6.1
3.8
estimate
0.0
0.0
0.00
75
486
(40767503) Oxygen content in Capillary blood by calculation
30
115
2.68
5.72
3.7
2.5
%
17.3
16.1
0.93
16
56
(3014007) Fractional oxyhemoglobin in Arterial blood
62
327
1.99
5.66
11.0
8.9
%
95.1
94.3
0.69
62
322
(3044640) Blood type and Crossmatch panel - Blood
222
1656
1.51
5.64
3.0
2.4
—
—
—
0
0
(3018418) pH of Serum or Plasma
217
1637
1.48
5.13
4.1
3.8
ph
7.4
7.4
0.63
64
306
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
54
281
2.00
5.13
12.7
11.3
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
18
55
3.34
5.06
1.2
1.1
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
460
5113
0.67
4.98
4.7
5.0
mmol/l
2.7
2.7
0.10
414
4670
(3007853) Bacteria identified in Skin by Aerobe culture
100
639
1.66
4.89
2.3
1.6
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
298
2407
1.43
4.86
5.5
4.1
—
—
—
0
0
(3030981) Hyaline casts [#/volume] in Urine by Automated count
53
282
1.96
4.75
3.6
2.9
e6/l
0.2
0.2
0.15
53
274
(44806118)
20
69
2.96
4.64
1.5
1.6
—
—
—
0
0
(44790047)
20
69
2.96
4.64
1.5
1.6
—
—
—
0
0
(44790049)
20
69
2.96
4.64
1.5
1.6
—
—
—
0
0
(44790048)
20
69
2.96
4.64
1.5
1.6
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
217
1667
1.45
4.59
2.6
2.4
u/l
50.9
55.6
1.70
200
1552
(3009261) Glucose [Presence] in Urine by Test strip
317
2612
1.41
4.51
6.3
3.9
estimate
0.0
0.0
0.00
73
468
(3002582) Erythrocytes [#/volume] in Urine
217
1672
1.44
4.50
4.3
3.4
e6/l
79.7
106.0
0.21
186
1298
(3021601) Nitrite [Presence] in Urine by Test strip
313
2582
1.40
4.39
8.1
5.3
estimate
0.0
0.0
0.00
76
479
(3000081) cloZAPine [Moles/volume] in Serum or Plasma
12
31
3.92
4.27
14.3
15.4
nmol/l
1399.8
1469.9
0.10
12
31
(21494755) Public health laboratory ask at order entry panel
14
391
0.34
4.14
1.1
1.4
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
449
4966
0.70
4.14
4.2
4.4
mmol/l
1.4
1.5
2.94
404
4538
(3011397) Hemoglobin [Presence] in Urine by Test strip
161
1201
1.45
3.90
5.7
3.9
—
—
—
0
0
(3000492) Spirometry study
19
448
0.41
3.87
1.1
1.5
—
—
—
0
0
(3036489) Thrombin time
37
188
2.03
3.80
2.1
2.7
s
20.4
21.6
1.10
30
172
(3024561) Albumin [Mass/volume] in Serum or Plasma
280
2306
1.37
3.80
6.4
4.6
g/l
34.4
35.5
2.48
255
2132
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
455
5000
0.72
3.79
4.3
4.4
mmol/l
4.6
4.6
0.45
409
4600
(3008832) Norclozapine [Moles/volume] in Serum or Plasma
11
30
3.71
3.65
9.7
11.3
nmol/l
686.6
812.3
0.36
11
30
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
15
381
0.38
3.64
1.5
1.7
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
155
2010
0.70
3.63
2.0
2.2
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
329
2795
1.35
3.60
5.8
5.9
umol/l
9.7
12.1
4.35
307
2642
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
20
80
2.55
3.57
2.1
1.5
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
29
140
2.12
3.42
1.9
1.7
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
9
18
5.05
3.38
1.1
1.1
miu/ml
1927.0
1488.5
—
9
18
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
10
27
3.74
3.36
1.0
1.1
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
63
396
1.65
3.31
2.5
2.7
ml/min/173m2
57.4
63.8
0.53
23
166
(3015377) Calcium [Moles/volume] in Serum or Plasma
228
1850
1.35
3.30
3.1
3.2
mmol/l
2.4
2.4
0.11
199
1603
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
28
136
2.11
3.27
2.0
1.7
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
192
1526
1.36
3.15
4.0
3.3
e6/l
0.4
0.4
0.40
165
1157
(3018095) Leukocytes [#/volume] in Urine
234
1917
1.34
3.15
5.0
4.0
e6/l
130.4
131.7
0.01
194
1384
(3002032) Base excess in Venous blood by calculation
81
549
1.54
3.12
5.9
4.4
mmol/l
2.3
1.8
0.61
63
431
(40761536) Microorganisms panel - Urine sediment
68
443
1.60
3.10
7.4
4.0
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
61
387
1.63
3.10
2.5
1.6
—
—
—
0
0
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
6
8
7.56
3.06
1.0
1.4
—
—
—
0
0
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
7
12
5.88
3.02
1.4
1.1
—
—
—
0
0
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
7
12
5.88
3.02
1.7
1.1
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
6
196
0.30
2.97
1.2
1.6
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
161
1258
1.37
2.92
2.9
2.4
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
440
4798
0.75
2.89
3.9
4.0
mmol/l
1.4
1.3
2.48
396
4363
(3022217) INR in Platelet poor plasma by Coagulation assay
101
729
1.45
2.88
24.4
25.7
inr
1.2
1.2
0.02
13
96
(3020393) Adenovirus Ag [Presence] in Stool
6
9
6.71
2.87
2.3
1.0
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
71
477
1.55
2.85
2.1
2.5
ug/l
6.2
6.9
0.08
59
417
(3036481) Cortisol [Moles/volume] in Serum or Plasma
74
503
1.53
2.83
2.3
2.0
nmol/l
380.2
385.4
0.07
66
461
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
8
18
4.48
2.80
1.1
1.2
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
8
18
4.48
2.80
1.0
1.2
—
—
—
0
0
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
8
18
4.48
2.80
1.0
1.1
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
40
656
0.58
2.80
4.0
4.4
%
30.4
32.1
0.60
32
429
(3000991) Gas panel - Venous blood
71
484
1.52
2.68
8.7
8.1
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
131
1672
0.73
2.65
3.3
2.9
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
10
261
0.37
2.63
1.4
1.4
—
—
—
0
0
(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid
5
7
7.19
2.55
1.2
1.6
—
—
—
0
0
(40757373) Influenza virus identified in Isolate
6
11
5.49
2.55
1.2
1.5
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
181
1470
1.32
2.51
4.1
3.3
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
402
3620
1.28
2.47
6.3
4.4
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
8
21
3.84
2.47
1.1
1.0
—
—
—
0
0
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
5
8
6.29
2.37
1.0
2.0
umol/l
19.7
14.7
—
5
8
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
31
177
1.79
2.34
1.5
1.2
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
15
65
2.34
2.33
2.3
1.5
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
105
1359
0.73
2.30
1.7
1.7
mmol/l
1.5
1.4
1.15
84
1141
(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay
6
13
4.65
2.27
2.3
3.2
%
101.7
123.0
—
6
13
(3028626) Oxygen [Partial pressure] in Capillary blood
35
210
1.70
2.24
12.0
4.5
kpa
8.8
8.6
0.28
35
189
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
441
4750
0.79
2.19
5.9
5.9
mmol/mol
39.9
40.0
0.05
402
4376
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
465
4977
0.78
2.19
4.4
4.6
mmol/l
6.0
6.0
0.04
415
4490
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
9
30
3.03
2.15
1.4
1.2
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
438
4714
0.79
2.11
23.7
15.9
%
39.2
39.5
0.22
248
3319
(3023419) Bacteria identified in Sputum by Culture
15
69
2.20
2.06
2.3
2.3
—
—
—
0
0
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
7
179
0.38
2.04
1.1
1.7
—
266.7
—
0
6
(3021901) Oxygen saturation in Capillary blood
21
111
1.92
2.03
5.0
2.6
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
7
21
3.36
1.97
1.1
1.3
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
14
64
2.21
1.95
1.2
1.3
—
—
—
0
0
(3052592) Norovirus Ag [Presence] in Stool
5
11
4.57
1.94
4.6
1.0
—
—
—
0
0
(4306422)
13
58
2.27
1.92
1.7
1.3
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
134
1083
1.30
1.90
4.1
4.0
ng/l
1129.8
369.6
0.54
99
864
(3028679) Herpes simplex virus Ab [Presence] in Serum
7
22
3.20
1.88
1.3
1.2
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
9
34
2.67
1.87
2.9
2.6
—
—
—
0
0
(1002224) Polysomnography panel
9
199
0.44
1.86
1.0
1.1
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
63
454
1.43
1.86
2.1
2.6
e9/l
75.4
70.1
0.64
52
354
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
66
889
0.71
1.85
2.3
2.9
ug/l
0.8
0.8
0.19
46
583
(3021960) Folate [Moles/volume] in Serum or Plasma
157
1301
1.27
1.83
1.6
1.5
nmol/l
20.5
20.9
0.08
141
1091
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
551
5240
1.30
1.79
24.7
14.6
mg/l
23.7
24.3
0.13
474
4130
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
127
1028
1.29
1.78
2.7
2.9
mmol/l
2.5
2.5
0.69
116
896
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
17
89
1.93
1.71
7.4
2.5
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
16
83
1.95
1.65
1.1
1.4
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
18
98
1.86
1.63
1.6
1.6
—
—
—
0
0
(3022145) Colonoscopy Study observation
39
563
0.67
1.62
1.2
1.3
—
—
—
0
0
(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma
5
14
3.59
1.62
1.0
1.9
umol/l
4.7
3.9
—
5
14
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
429
3992
1.21
1.57
4.1
3.8
pmol/l
15.3
14.8
3.11
387
3586
(3019550) Sodium [Moles/volume] in Serum or Plasma
562
5381
1.29
1.57
28.1
17.3
mmol/l
139.7
139.6
0.25
549
5229
(3023103) Potassium [Moles/volume] in Serum or Plasma
563
5393
1.29
1.56
27.1
17.4
mmol/l
4.0
4.0
2.50
549
5234
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
5
15
3.35
1.52
1.0
1.3
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
21
123
1.73
1.52
1.3
1.4
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
155
1310
1.24
1.52
1.4
1.4
—
—
—
0
0
(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma
6
21
2.87
1.51
1.7
3.0
umol/l
29.7
27.6
—
6
21
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
12
228
0.52
1.48
2.5
1.8
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
54
397
1.39
1.46
9.2
4.9
mmol/l
2.3
1.9
0.42
44
298
(3041096) Erythrocytes [Presence] in Urine by Automated
166
1420
1.23
1.45
6.8
3.5
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
80
627
1.31
1.44
2.1
2.7
%
1.8
1.8
0.18
71
558
(3044889) 12 lead EKG panel
395
3665
1.19
1.43
4.1
3.9
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
35
502
0.68
1.42
1.6
1.6
—
—
—
0
0
(4034850)
25
158
1.61
1.39
12.7
10.5
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
53
701
0.73
1.35
1.3
1.2
—
—
—
0
0
(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence
0
39
0.00
1.34
0.0
1.3
—
24.0
—
0
5
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
159
1368
1.21
1.31
2.6
2.2
mg/l
3.3
3.1
0.20
137
1160
(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum
6
24
2.51
1.30
2.5
2.0
ug/l
132.8
73.2
—
6
24
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
17
99
1.74
1.28
2.5
1.6
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
11
55
2.02
1.28
1.1
1.2
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
9
44
2.06
1.27
2.6
1.6
—
—
—
0
0
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
42
305
1.40
1.25
5.8
4.8
mmol/l
24.5
24.0
0.73
37
276
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
8
36
2.24
1.24
1.1
1.0
—
—
—
0
0
(3002256) Pathology report gross observation
49
646
0.74
1.24
1.2
1.3
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
12
63
1.92
1.23
1.3
1.7
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
32
222
1.46
1.21
1.5
1.9
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
65
820
0.77
1.21
1.2
1.3
u/ml
9.0
10.8
0.15
30
293
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
25
165
1.54
1.19
3.0
3.0
u/ml
0.4
0.4
0.25
14
91
(1001926) Buprenorphine [Presence] in Urine by Screen method
22
141
1.58
1.18
1.3
1.4
—
—
—
0
0
(3018010) Neutrophils/100 leukocytes in Blood
228
2525
0.85
1.17
6.5
5.6
%
57.8
57.2
0.33
216
2359
(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma
0
33
0.00
1.16
0.0
1.2
—
16.3
—
0
27
(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma
0
34
0.00
1.16
0.0
1.2
—
69.7
—
0
29
(3000060) B lymphocytes [#/volume] in Blood
5
20
2.51
1.15
2.0
2.4
e6/l
544.0
486.0
—
5
5
(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma
5
20
2.51
1.15
1.0
1.2
g/l
0.3
0.3
—
5
15
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
55
424
1.32
1.14
9.5
4.8
kpa
5.4
5.2
0.87
55
392
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
12
65
1.86
1.14
2.3
1.7
pg
32.2
32.7
0.15
12
65
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
533
5518
0.83
1.13
11.1
10.2
u/l
27.4
25.9
0.55
512
5308
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
7
137
0.51
1.10
1.4
1.4
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
9
164
0.54
1.09
1.6
1.6
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
29
202
1.46
1.09
2.6
3.5
g/l
0.4
0.3
0.17
14
81
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
5
21
2.39
1.09
7.0
6.4
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
15
89
1.70
1.08
1.4
1.5
—
—
—
0
0
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
429
4057
1.16
1.08
7.4
7.2
u/l
83.3
80.6
0.41
401
3784
(3009343) pH of Capillary blood
54
420
1.31
1.07
9.5
4.8
ph
7.4
7.4
0.11
14
42
(4027681)
7
33
2.13
1.06
1.1
1.1
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
44
333
1.34
1.05
1.2
1.2
iu/ml
133.1
162.6
0.22
22
128
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
10
178
0.56
1.04
2.1
1.7
—
—
—
0
0
(3020630) Protein [Mass/volume] in Serum or Plasma
57
449
1.29
1.03
2.2
2.9
g/l
67.0
66.2
0.29
51
404
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
5
22
2.28
1.03
1.0
1.1
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
19
122
1.57
1.03
2.2
2.1
u/l
4710.4
4668.3
—
5
39
(36660697) Celiac disease serology panel - Serum
29
402
0.71
1.02
1.2
1.2
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
239
2174
1.16
1.01
2.5
2.3
nmol/l
74.9
77.7
0.76
218
1924
(4010399)
27
377
0.70
1.00
1.4
1.4
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
11
61
1.82
0.99
3.0
2.9
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
184
1644
1.16
0.98
2.9
3.2
ng/l
978.5
1506.5
1.89
156
1405
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
7
36
1.95
0.97
1.7
1.2
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
134
1168
1.18
0.97
2.0
1.8
mg/l
2.3
1.2
0.76
105
912
(4062490)
9
50
1.81
0.97
3.6
1.2
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
0
32
0.00
0.95
0.0
1.5
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
0
32
0.00
0.95
0.0
1.5
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
14
85
1.66
0.95
1.7
1.6
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
7
37
1.90
0.94
4.3
1.9
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
32
429
0.73
0.94
1.8
1.9
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
6
27
2.23
0.93
2.5
1.6
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
6
28
2.15
0.91
2.5
1.6
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
238
2178
1.14
0.91
2.1
2.0
pmol/l
93.2
94.0
0.10
128
1088
(3009445) Proteinase 3 Ab [Units/volume] in Serum
15
228
0.65
0.87
1.0
1.4
—
10.1
—
0
5
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
43
336
1.30
0.85
1.8
1.7
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
13
80
1.64
0.85
1.8
1.7
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
126
1108
1.17
0.83
5.8
4.8
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
11
65
1.70
0.82
1.2
1.1
—
—
—
0
0
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
24
172
1.41
0.82
1.9
2.2
ug/l
513.4
522.1
0.01
18
159
(3033705) Calcium.ionized [Moles/volume] in Venous blood
13
81
1.62
0.81
2.3
2.7
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
37
473
0.77
0.80
1.9
2.1
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
38
483
0.77
0.79
2.8
2.4
u/l
28.7
31.1
0.30
29
401
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
6
33
1.83
0.79
1.3
1.3
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
6
33
1.83
0.79
1.3
1.3
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
8
48
1.67
0.79
1.0
1.2
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
460
4773
0.88
0.77
18.1
13.7
ml/min/173m2
81.8
78.8
1.83
395
3912
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
0
28
0.00
0.76
0.0
1.1
—
—
—
0
0
(40768443) Skin Pathology biopsy report
15
220
0.67
0.75
1.1
1.2
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
20
141
1.43
0.75
1.3
1.5
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
52
631
0.81
0.74
2.3
2.3
ug/g
287.2
138.6
0.44
40
495
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
18
125
1.45
0.73
1.4
1.4
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
18
125
1.45
0.73
1.4
1.4
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
140
1556
0.87
0.73
3.8
4.9
ug/l
3.8
2.7
0.39
118
1386
(4035726)
54
445
1.23
0.72
1.4
1.4
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
9
57
1.59
0.71
1.4
1.8
—
—
—
0
0
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
5
26
1.93
0.70
1.4
2.9
u/ml
1728.0
772.3
—
5
26
(3037522) Nuclear Ab [Titer] in Serum
56
669
0.82
0.70
1.3
1.4
titre
800.0
450.5
0.34
11
148
(3019225) pH of Specimen
42
517
0.80
0.69
3.9
4.1
—
—
—
0
0
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
22
161
1.38
0.69
12.4
5.8
mg/l
1.9
1.5
1.13
22
147
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
5
27
1.86
0.68
1.6
1.1
—
—
—
0
0
(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma
5
27
1.86
0.68
1.0
1.1
u/l
38.8
19.6
—
5
19
(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma
5
27
1.86
0.68
1.0
1.1
u/l
130.6
74.0
—
5
19
(3051651) Icteric interference index of Serum or Plasma
7
42
1.67
0.68
2.7
2.6
—
—
—
0
0
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
36
285
1.28
0.68
2.8
3.0
pmol/l
4.5
4.6
0.01
31
247
(3022096) Basophils/100 leukocytes in Blood
226
2427
0.90
0.67
6.6
5.8
%
0.6
0.7
1.18
217
2259
(44816559) Phosphatidylethanol [Mass/volume] in Blood
5
94
0.53
0.67
1.0
1.2
—
—
—
0
0
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
58
487
1.21
0.66
2.0
2.4
g/l
0.2
0.2
0.47
52
457
(3004451) EKG impression Narrative
5
28
1.79
0.66
1.6
1.3
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
60
707
0.83
0.66
1.3
1.4
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
111
1244
0.87
0.65
3.2
4.3
%
18.0
21.7
2.22
49
588
(3006504) Eosinophils/100 leukocytes in Blood
233
2494
0.90
0.65
6.6
5.7
%
2.6
2.9
1.26
222
2314
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
52
433
1.22
0.65
3.3
3.9
ng/l
91.0
82.6
0.26
44
387
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
75
865
0.85
0.65
1.2
1.3
iu/ml
34.3
37.3
0.08
30
271
(3026493) Urate [Moles/volume] in Serum or Plasma
118
1315
0.88
0.64
2.8
2.7
umol/l
341.2
6794.8
5.44
103
1122
(40768793) Breast Pathology biopsy report
8
128
0.62
0.64
1.4
1.3
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
5
29
1.73
0.64
1.4
4.0
—
—
—
0
0
(3002030) Lymphocytes/100 leukocytes in Blood
240
2561
0.90
0.63
6.6
5.8
%
27.1
27.8
0.46
227
2379
(3016879) Cocaine [Presence] in Urine
23
173
1.34
0.62
1.3
1.5
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
24
182
1.33
0.62
2.9
2.9
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
10
63
1.60
0.62
1.2
1.2
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
9
138
0.65
0.61
1.4
1.2
—
—
—
0
0
(3000963) Hemoglobin [Mass/volume] in Blood
569
5799
0.87
0.59
33.9
21.5
g/l
131.0
134.4
6.09
557
5697
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
8
52
1.54
0.59
1.8
1.5
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
0
22
0.00
0.59
0.0
1.2
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
8
53
1.52
0.58
2.9
1.5
—
—
—
0
0
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
0
23
0.00
0.58
0.0
1.1
—
203.6
—
0
23
(3010813) Leukocytes [#/volume] in Blood
569
5797
0.87
0.58
33.6
21.4
e9/l
7.2
6.8
4.24
550
5616
(3003329) Lymphocytes/100 leukocytes in Synovial fluid
6
35
1.72
0.58
2.3
1.3
%
21.2
33.0
—
6
21
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
6
35
1.72
0.58
2.5
1.5
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
51
430
1.20
0.57
4.2
4.3
%
1.0
1.0
0.03
13
141
(3026361) Erythrocytes [#/volume] in Blood
569
5796
0.87
0.57
33.6
21.4
e12/l
4.4
4.5
4.67
550
5616
(3004716) Salmonella sp identified in Stool by Organism specific culture
21
274
0.76
0.57
1.4
1.2
—
—
—
0
0
(3035941) MCH [Entitic mass]
569
5795
0.87
0.56
33.4
21.3
pg
30.2
30.3
0.66
555
5696
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
11
73
1.52
0.56
1.8
1.7
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
17
124
1.38
0.56
1.6
1.4
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
13
90
1.45
0.55
3.2
2.9
e9/l
6.1
4.4
0.54
13
90
(3024731) MCV [Entitic volume]
569
5794
0.88
0.55
33.5
21.3
fl
90.8
91.0
0.41
555
5696
(3007461) Platelets [#/volume] in Blood
569
5793
0.88
0.55
33.5
21.4
e9/l
259.2
248.3
3.16
551
5634
(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood
6
38
1.58
0.54
2.2
2.3
e9/l
0.1
0.2
—
6
29
(3025159) Blasts/100 leukocytes in Blood
46
387
1.20
0.54
4.2
4.5
%
0.0
0.9
—
8
110
(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay
9
61
1.48
0.54
3.3
1.4
u/l
9.4
29.3
—
9
51
(42529406) Shigella sp [Presence] in Stool by Culture
13
181
0.71
0.53
1.4
1.2
—
—
—
0
0
(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood
6
39
1.54
0.53
2.2
2.3
e6/l
549.2
548.1
—
6
29
(3019069) Monocytes/100 leukocytes in Blood
237
2511
0.91
0.52
6.9
6.0
%
8.7
8.7
0.09
228
2347
(3048929) Epstein Barr virus Ab [Presence] in Serum
21
161
1.31
0.52
1.4
1.4
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
23
179
1.30
0.52
1.3
1.5
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
23
179
1.30
0.52
1.3
1.5
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
48
562
0.84
0.51
4.0
3.8
ug/l
4.6
30.4
1.15
41
472
(3008898) HLA-B27 [Presence]
14
191
0.73
0.51
1.1
1.1
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
37
443
0.83
0.50
1.6
1.5
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
13
179
0.72
0.50
1.4
1.2
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
13
178
0.72
0.49
1.4
1.2
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
7
47
1.49
0.47
1.3
1.2
—
—
—
0
0
(4024509)
7
47
1.49
0.47
1.4
1.4
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
248
2351
1.09
0.47
13.4
9.3
e9/l
0.0
0.0
0.67
214
1922
(3004588) Protein electrophoresis panel - Serum or Plasma
44
375
1.19
0.46
2.0
2.4
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
16
120
1.34
0.46
1.4
1.7
—
—
—
0
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
54
469
1.16
0.46
3.1
3.1
ng/l
169.4
204.5
0.33
47
426
(3017446) Testosterone [Moles/volume] in Serum or Plasma
28
341
0.81
0.46
2.1
2.2
nmol/l
13.9
12.8
0.28
22
307
(3025130) Human papilloma virus identified in Specimen
7
49
1.43
0.46
3.1
1.9
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
7
49
1.43
0.46
2.3
2.3
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
5
81
0.61
0.46
1.0
1.1
—
—
—
0
0
(4268621)
7
50
1.40
0.45
3.7
2.1
—
—
—
0
0
(3000012) Reticulocyte production index
5
31
1.62
0.43
1.4
1.8
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
5
32
1.57
0.42
5.8
2.7
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
13
96
1.36
0.42
4.8
3.1
%
64.7
58.5
0.69
13
96
(3021879) Hepatitis B virus core Ab [Presence] in Serum
29
347
0.83
0.41
1.3
1.3
—
—
—
0
0
(3033923) Metanephrine [Moles/time] in 24 hour Urine
0
15
0.00
0.41
0.0
1.1
—
0.7
—
0
8
(3013115) Eosinophils [#/volume] in Blood
262
2739
0.93
0.40
7.0
5.9
e9/l
0.2
0.2
0.58
242
2410
(3038071) Oxygen [Partial pressure] in Mixed venous blood
0
17
0.00
0.40
0.0
11.8
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
93
1018
0.90
0.40
1.8
1.5
g/l
2.2
2.4
0.47
62
596
(21491868) Cryoglobulin [Mass/volume] in Serum
0
18
0.00
0.40
0.0
1.1
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
25
302
0.82
0.39
1.3
1.2
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
10
71
1.41
0.39
1.3
1.3
—
—
—
0
0
(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum
0
19
0.00
0.39
0.0
1.2
—
17.0
—
0
12
(3017732) Neutrophils [#/volume] in Blood
40
347
1.16
0.36
6.7
2.7
e9/l
3.3
4.0
1.41
30
269
(3028300) Cannabinoids [Presence] in Urine
22
180
1.23
0.36
1.3
1.5
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
5
78
0.64
0.36
1.2
1.1
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
46
405
1.15
0.35
4.1
4.4
%
0.5
0.2
0.35
11
129
(3003327) Ova and parasites identified in Stool by Light microscopy
12
156
0.76
0.35
1.6
1.6
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
26
218
1.20
0.34
1.9
1.9
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
21
172
1.23
0.34
3.3
2.0
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
12
91
1.32
0.34
1.4
1.4
u/ml
180.9
243.4
—
7
42
(3000330) Specific gravity of Urine by Test strip
32
275
1.17
0.33
5.0
3.9
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
6
46
1.31
0.33
1.5
1.1
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
57
632
0.89
0.32
1.6
1.6
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
11
143
0.77
0.32
1.3
1.2
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
401
3911
1.06
0.32
3.9
4.1
mm/h
15.0
12.6
1.91
364
3578
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
10
75
1.34
0.30
1.9
1.5
—
—
—
0
0
(3003338) MCHC [Mass/volume]
429
4381
0.94
0.30
31.2
19.2
g/l
332.1
332.3
0.14
419
4347
(3015171) Extractable nuclear Ab [Units/volume] in Serum
22
185
1.20
0.29
1.2
1.2
u/ml
0.3
2.1
—
5
14
(3009508) Creatinine [Moles/volume] in Urine
169
1610
1.07
0.28
3.4
3.2
mmol/l
7.3
7.4
0.03
145
1335
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
60
547
1.11
0.28
1.6
1.7
%
1.5
1.5
0.42
53
488
(3002385) Erythrocyte distribution width [Ratio]
426
4344
0.95
0.27
27.0
17.9
%
13.8
13.7
0.74
419
4257
(3024522) Salmonella sp identified in Specimen by Organism specific culture
5
71
0.70
0.26
1.2
1.4
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
5
71
0.70
0.26
1.2
1.4
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
5
71
0.70
0.26
1.2
1.4
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
5
72
0.69
0.26
1.2
1.3
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
5
73
0.68
0.26
1.2
1.2
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
43
387
1.12
0.26
4.0
4.3
%
1.3
0.5
—
6
103
(3013512) EKG study
163
1558
1.06
0.25
4.0
3.9
—
—
—
0
0
(3003434) Protein [Mass/volume] in Pleural fluid
9
74
1.22
0.25
1.6
1.5
g/l
33.3
31.1
—
9
65
(3027008) Opiates [Presence] in Urine
21
179
1.18
0.25
1.3
1.5
—
—
—
0
0
(3006315) Basophils [#/volume] in Blood
257
2652
0.95
0.25
6.7
5.6
e9/l
0.0
0.0
0.23
236
2293
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
35
312
1.13
0.24
1.3
1.4
—
31.5
—
0
13
(40768800) Prostate Pathology biopsy report
6
85
0.70
0.24
1.0
1.2
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
5
38
1.32
0.23
1.4
3.7
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
5
38
1.32
0.23
1.0
1.2
—
—
—
0
0
(3022621) pH of Urine by Test strip
39
352
1.11
0.23
6.1
3.1
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
18
153
1.18
0.22
6.5
4.9
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
5
41
1.22
0.22
1.0
1.3
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
16
135
1.19
0.21
1.4
1.4
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
23
201
1.15
0.21
2.0
1.7
—
—
—
0
0
(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay
0
11
0.00
0.21
0.0
1.0
—
23.0
—
0
11
(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum
0
11
0.00
0.21
0.0
1.0
—
1.7
—
0
6
(3032057) Clostridioides difficile [Presence] in Stool
0
11
0.00
0.21
0.0
1.9
—
—
—
0
0
(40761873) Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum
0
11
0.00
0.21
0.0
1.0
—
32.3
—
0
6
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
0
11
0.00
0.21
0.0
1.5
—
—
—
0
0
(3008116) Ketones [Moles/volume] in Urine by Test strip
0
11
0.00
0.21
0.0
1.4
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
99
937
1.07
0.21
3.4
3.0
e6/l
1.5
1.0
0.63
72
544
(3033799) Differential panel - Peritoneal fluid
0
12
0.00
0.21
0.0
1.3
—
—
—
0
0
(3005011) Chlamydia sp Ab [Titer] in Serum
0
12
0.00
0.21
0.0
1.5
—
—
—
0
0
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
0
12
0.00
0.21
0.0
1.3
—
—
—
0
0
(3000285) Sodium [Moles/volume] in Blood
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(3048879) Bone marrow aspiration report
0
12
0.00
0.21
0.0
2.8
—
—
—
0
0
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
0
12
0.00
0.21
0.0
1.3
—
—
—
0
0
(3034037) Hematocrit [Volume Fraction] of Mixed venous blood
0
12
0.00
0.21
0.0
15.7
—
—
—
0
0
(3042299) inFLIXimab [Mass/volume] in Serum or Plasma
0
12
0.00
0.21
0.0
6.1
—
7.0
—
0
12
(3017817) Protein [Mass] in Urine collected for unspecified duration
5
43
1.16
0.21
1.4
2.9
—
—
—
0
0
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
0
13
0.00
0.21
0.0
1.4
—
—
—
0
0
(3002619) Bacteria identified in Specimen by Culture
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
0
14
0.00
0.20
0.0
1.5
—
—
—
0
0
(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma
0
14
0.00
0.20
0.0
1.9
—
2.2
—
0
6
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
0
14
0.00
0.20
0.0
1.2
—
—
—
0
0
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
0
14
0.00
0.20
0.0
1.2
—
—
—
0
0
(3010144) Erythrocytes [#/volume] in Synovial fluid
6
49
1.23
0.20
2.0
1.2
e6/l
3650.7
150371.6
—
6
34
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
175
1689
1.05
0.20
3.8
3.1
u/l
58.5
33.8
0.46
166
1610
(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal
6
50
1.20
0.19
1.2
1.1
nmol/l
1.7
1.6
—
6
44
(3000494) Fungus identified in Specimen by Culture
66
618
1.08
0.19
1.5
1.4
—
—
—
0
0
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
12
143
0.84
0.18
1.1
1.1
—
14.0
—
0
15
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
19
166
1.15
0.18
1.5
1.6
iu/ml
0.0
0.0
—
6
31
(3007566) Smooth muscle Ab [Titer] in Serum
10
121
0.82
0.18
1.1
1.3
—
58.9
—
0
9
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
10
121
0.82
0.18
1.4
1.2
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
75
793
0.94
0.18
1.7
1.7
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
7
63
1.11
0.17
1.4
1.6
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
5
70
0.71
0.16
1.2
1.3
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
8
72
1.11
0.16
1.1
1.1
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
50
534
0.93
0.16
1.5
1.5
—
—
—
0
0
(3001604) Monocytes [#/volume] in Blood
258
2636
0.97
0.15
6.5
5.6
e9/l
0.6
0.6
0.11
235
2271
(3042631) Mycobacterium sp identified in Specimen
9
79
1.14
0.15
2.4
2.8
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
9
82
1.10
0.15
1.1
1.2
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
93
891
1.05
0.14
3.8
3.1
e6/l
3.1
2.1
0.45
66
498
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
7
87
0.80
0.14
1.1
1.2
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
11
93
1.19
0.14
1.5
1.5
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
23
208
1.11
0.14
1.6
2.0
g/l
7.0
7.5
0.37
14
154
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
23
208
1.11
0.14
1.6
2.0
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
60
631
0.95
0.13
2.6
2.8
umol/l
5.8
7.7
0.78
45
557
(3022948) Iron [Moles/volume] in Serum or Plasma
87
836
1.05
0.12
3.0
2.4
umol/l
11.4
12.7
0.84
76
769
(3012516) Albumin [Mass/volume] in Urine
145
1488
0.97
0.11
3.2
3.2
mg/l
407.1
215.0
0.23
100
956
(3019198) Lymphocytes [#/volume] in Blood
265
2693
0.97
0.11
6.6
5.7
e9/l
1.8
2.0
0.80
244
2381
(3020682) Albumin/Creatinine [Ratio] in Urine
153
1567
0.97
0.11
4.1
4.0
mg/mmol
14.3
8.7
0.49
102
985
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
25
269
0.93
0.10
4.2
2.9
u/ml
45.2
68.6
0.52
25
257
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
29
271
1.07
0.10
3.1
2.5
—
—
—
0
0
(3011648) Oxygen content in Venous blood
5
47
1.06
0.09
1.2
5.2
%
10.7
10.9
—
5
47
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
480
4766
1.03
0.09
5.0
4.7
mu/l
2.0
2.2
0.39
437
4319
(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma
11
124
0.89
0.09
1.3
1.7
nmol/l
40.8
40.8
0.00
11
119
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
325
3287
0.98
0.09
3.3
3.1
u/l
54.1
47.9
0.56
301
3058
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
11
97
1.14
0.09
1.5
1.4
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
27
288
0.93
0.09
1.6
1.3
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
6
54
1.11
0.09
1.0
1.3
nmol/l
—
—
—
0
0
(21494434) Karyotype in Bone marrow
6
56
1.07
0.08
1.7
1.1
—
—
—
0
0
(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood
6
58
1.03
0.08
1.0
1.1
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
5
62
0.80
0.08
2.0
1.2
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
5
65
0.77
0.08
1.4
1.1
—
—
—
0
0
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
21
195
1.08
0.08
1.4
2.0
g/l
9.4
10.1
0.52
16
167
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
311
3143
0.98
0.08
3.0
2.9
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
14
127
1.10
0.08
1.3
1.3
miu/ml
97.6
244.7
—
5
61
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
12
133
0.90
0.07
2.1
2.6
ug/min
118.5
92.7
—
7
81
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
6
71
0.84
0.07
1.5
1.4
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
6
70
0.86
0.07
1.2
1.3
—
—
—
0
0
(3022313) Gas panel - Capillary blood
31
327
0.95
0.07
12.0
4.6
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
545
5424
1.03
0.07
24.1
13.7
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
304
3071
0.98
0.07
12.1
8.7
e9/l
4.4
4.2
0.65
282
2682
(3004809) Band form neutrophils/100 leukocytes in Blood
7
82
0.85
0.07
3.7
3.8
%
2.4
1.6
—
7
70
(3050129) First trimester maternal screen panel - Serum or Plasma
7
85
0.82
0.07
1.4
1.4
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
9
86
1.05
0.07
1.7
1.5
—
—
—
0
0
(3027456) Digoxin [Moles/volume] in Serum or Plasma
11
122
0.90
0.07
3.7
3.1
nmol/l
0.7
0.9
0.76
11
94
(3042111) Morphology [Interpretation] in Bone marrow Narrative
8
90
0.89
0.07
4.0
1.7
—
—
—
0
0
(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay
9
102
0.88
0.06
2.0
3.2
u/ml
33.8
2778.3
—
9
97
(3024891) Influenza virus A+B Ag [Presence] in Specimen
16
148
1.08
0.06
1.3
1.2
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
117
1150
1.02
0.05
1.3
1.3
u/ml
1.0
2.2
1.17
41
273
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
22
208
1.06
0.05
1.6
2.0
g/l
3.6
3.8
0.26
13
149
(3049717) Cytology report of Urine Cyto stain
23
218
1.06
0.05
2.0
2.9
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
180
1779
1.02
0.05
5.8
5.7
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
28
268
1.05
0.04
1.0
1.0
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
14
130
1.08
0.04
1.1
1.1
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
14
130
1.08
0.04
1.3
4.9
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
17
160
1.06
0.04
2.9
1.7
—
—
—
0
0
(3020961) Endomysium IgA Ab [Titer] in Serum
24
250
0.96
0.03
1.1
1.1
—
66.8
—
0
9
(3004789) Transferrin [Mass/volume] in Serum or Plasma
78
767
1.02
0.03
3.0
2.4
g/l
2.3
2.3
0.30
70
708
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
20
191
1.05
0.03
1.7
2.0
g/l
3.1
3.2
0.22
14
151
(3001122) Ferritin [Mass/volume] in Serum or Plasma
220
2212
0.99
0.02
3.0
2.7
ug/l
113.5
127.7
0.49
189
2022
(40758558) Short blood count panel - Blood
133
1339
0.99
0.01
8.4
6.2
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
85
857
0.99
0.01
1.6
1.5
—
—
—
0
0
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
27
276
0.98
0.00
13.9
5.2
mmol/l
25.0
24.9
0.10
27
266
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
12
124
0.97
0.00
1.4
1.3
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
12
117
1.03
0.00
2.0
1.7
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
14
138
1.01
0.00
1.8
1.3
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
35
353
0.99
0.00
1.5
1.6
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
72
717
1.00
0.00
3.2
2.4
%
20.3
22.4
0.73
56
616
(3014051) Protein [Presence] in Urine by Test strip
12
119
1.01
0.00
2.1
2.3
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
12
121
0.99
0.00
4.8
4.6
—
—
—
0
0
(4094501)
13
131
0.99
0.00
1.0
1.1
—
—
—
0
0
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(3032868) Hemoglobin electrophoresis panel in Blood
0
8
0.00
0.00
0.0
1.6
—
—
—
0
0
(3022670) pH of Venous cord blood
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight
5
53
0.94
0.00
1.6
1.3
—
—
—
0
0
(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3009876) Amylase isoenzyme 3 panel - Serum or Plasma
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3022411) Androstenedione [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
3.4
—
5.4
—
0
5
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
6
59
1.02
0.00
1.0
1.3
—
—
—
0
0
(3007302) Hemoglobin [Mass/volume] in Mixed venous blood
0
5
0.00
0.00
0.0
2.2
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
7
73
0.96
0.00
1.6
1.1
—
—
—
0
0
(3040893) Potassium [Moles/volume] in Capillary blood
0
6
0.00
0.00
0.0
1.5
—
4.3
—
0
6
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
5
51
0.98
0.00
1.2
1.4
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
5
52
0.96
0.00
1.0
1.1
—
—
—
0
0
(40760435) Tropomyosin IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
6
61
0.98
0.00
1.7
4.6
—
—
—
0
0
(3050794) Legionella sp Ab [Presence] in Serum
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
3.7
—
55.6
—
0
7
(3013336) Amino acids [Identifier] in Serum or Plasma
0
9
0.00
0.00
0.0
3.7
—
—
—
0
0
(3011544) Albumin [Mass/volume] in Pleural fluid
0
9
0.00
0.00
0.0
1.0
—
18.3
—
0
9
(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
5
53
0.94
0.00
1.2
1.7
—
—
—
0
0
(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(44806071)
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3030313) Adrenal Ab [Titer] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3011335) Digoxin [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
2.2
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
7
73
0.96
0.00
1.6
1.1
—
—
—
0
0
(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3026179) Normetanephrine [Moles/volume] in Serum or Plasma
6
62
0.97
0.00
1.0
1.3
nmol/l
0.6
0.6
—
6
55
(3025315) Body weight
0
6
0.00
0.00
0.0
3.3
—
—
—
0
0
(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
5
53
0.94
0.00
1.2
1.7
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
5
53
0.94
0.00
1.2
1.7
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
12
120
1.00
0.00
1.2
1.3
—
—
—
0
0
(3032700) Glomerular basement membrane Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
5
53
0.94
0.00
2.2
1.3
%
90.8
59.6
—
5
36
(3000213) Normetanephrine [Moles/time] in 24 hour Urine
0
9
0.00
0.00
0.0
1.3
—
1.8
—
0
9
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
5
58
0.86
0.00
1.0
1.5
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
9
97
0.93
0.00
1.0
1.5
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
8
87
0.92
0.00
1.4
1.6
—
—
—
0
0
(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis
0
6
0.00
0.00
0.0
6.7
—
7.3
—
0
6
(3018081) Beta-2-Microglobulin [Mass/volume] in Urine
0
5
0.00
0.00
0.0
2.0
—
9.6
—
0
5
(3021162) Amylase [Enzymatic activity/volume] in Specimen
0
9
0.00
0.00
0.0
1.9
—
2068.3
—
0
9
(3041082) Glomerular basement membrane Ab [Titer] in Serum by Immunofluorescence
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3003721) Smooth muscle Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
6
59
1.02
0.00
1.5
1.4
—
—
—
0
0
(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(21494567) Legionella sp IgM Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3004446) Plasmodium sp identified in Blood by Light microscopy
0
5
0.00
0.00
0.0
2.4
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
7
74
0.95
0.00
1.1
1.1
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
5
50
1.00
0.00
1.0
1.0
—
—
—
0
0
(3002621) Streptococcal DNAse B [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3001729) Color of Synovial fluid
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3032743) Legionella sp IgG Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
17
170
1.00
0.00
4.0
3.1
—
—
—
0
0

Mortality – FinRegistry

↥

Association

Association between endpoint G6_HCOTHUNS and mortality.

Females

Parameter HR [95% CI] p-value
G6_HCOTHUNS 3.018 [2.63, 3.46] < 0.001
Birth year 0.998 [0.99, 1.01] 0.569

During the follow-up period (1.1.1998 — 31.12.2019), 789 out of 2228 females with G6_HCOTHUNS died.

Males

Parameter HR [95% CI] p-value
G6_HCOTHUNS 3.131 [2.67, 3.68] < 0.001
Birth year 0.983 [0.97, 0.99] < 0.001

During the follow-up period (1.1.1998 — 31.12.2019), 826 out of 2254 males with G6_HCOTHUNS died.

Mortality risk

Mortality risk for people of age

years, who have G6_HCOTHUNS.

N-year risk Females Males
1 0.299% 0.595%
5 2.223% 3.345%
10 5.219% 8.599%
15 10.012% 15.221%
20 16.312% 24.269%

Relationships between endpoints

↥

Index endpoint: G6_HCOTHUNS – Other and unspecified hydrocephalus

GWS hits: -

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data